GlassScriptPhysician profile
Nicholas L Schlageter
NPI 1285728873
$1,902.50
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,540 · 2020: $245 · 2021: $118.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $580.31 | 2019-2021 | |
| Biogen, INC. | $433.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $374.08 | 2019-2020 | |
| Genentech USA, INC. | $180.78 | 2019 | |
| Acorda Therapeutics, INC | $111.65 | 2019 | |
| Emd Serono, INC. | $97.53 | 2019 | |
| Alexion Pharmaceuticals, INC. | $82.57 | 2019 | |
| Lilly USA, LLC | $42.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Schlageter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.